Will submit clarification to EMA on clinical study data:Alkem Laboratories
Drug maker Alkem Laboratories on Saturday said it will submit 'suitable clarifications' to the European Medicines Agency (EMA) over a decision by the drug regulator to review two drugs for which clinical trial studies were conducted by the Mumbai-based firm
Apr 16, 2016, 18:26 PM IST
Japan's Daiichi completely exits Sun Pharma
Yesterday, Daiichi Sankyo Company Ltd had announced its decision to sell "the entire or part of its holdings of Sun Pharmaceutical shares..."
Apr 21, 2015, 12:40 PM IST
Sun settles Angiomax litigation with The Medicines Company
Drug major Sun Pharmaceutical Industries has entered into a settlement pact with US-based The Medicines Company for settling the lawsuit filed against it by the later for generic Angiomax.
Apr 01, 2015, 19:12 PM IST
Ranbaxy ends last trading day on bright note; surges over 5%
Shares of Ranbaxy Laboratories on Wednesday ended with strong gains on the last day of its trade, as the company is being merged with Sun Pharmaceutical in a USD 4 billion deal.
Apr 01, 2015, 19:07 PM IST
IPCA Labs aims to make plants US FDA-compliant by December
IPCA Laboratories Ltd is aiming to make all of its plants facing import alerts from the United States compliant with U.S. Food and Drug Administration (FDA) rules by December, an executive said on Wednesday.
Mar 25, 2015, 13:51 PM IST
IPCA slumps as FDA bans imports from 2 more plants
Shares in generic drugmaker IPCA Laboratories slumped as much 12.7 percent, heading towards their biggest daily fall since July 2014, after the U.S. Food and Drug Administration (FDA) issued an import alert against two of its plants.
Mar 25, 2015, 13:18 PM IST
US FDA did not find issues with Wockhardt's Chikalthana plant
"The recent inspection at the Aurangabad L1-Chikalthana site was a follow-up inspection by the US FDA as an outcome of completion of good manufacturing practise (GMP) remediation submitted by Wockhardt in October 2014.
Mar 18, 2015, 19:03 PM IST
Aurobindo Pharma may spend Rs 1,300 cr toward capex in FY15-16
Drug maker Aurobindo Pharma Limited may spend up to Rs 1,300 crore towards capex during the ongoing and next financial years.
Nov 17, 2014, 16:07 PM IST
Germany's Merck to buy US firm Sigma-Aldrich for $17 bn
German drug maker Merck KGaA will acquire US-based Sigma-Aldrich, led by Indian-origin CEO Rakesh Sachdev, for USD 17 billion in an all cash deal.
Sep 22, 2014, 23:01 PM IST
